Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-001019-19Phase 2Completed
Phase 2, single-arm trial of triheptanoin in migraine, sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoint: Primary outcome measures. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-001019-19.